Insiders · Profile

Bruno Julianne

Chief Operating Officer at CRISPR Therapeutics. Filing since 21 Jun 2024. CIK 0002019645

Company
Date
Role
Action
Shares
Amount
Of holding
21 Mar 2025
Chief Operating Officer
Sold at will
1,714
$70.67K
14.0%
12 Mar 2025
Chief Operating Officer
Sold at will
190
$8.23K
2.2%
11 Mar 2025
Chief Operating Officer
Sold at will
1,198
$50.82K
12.7%
19 Feb 2025
Chief Operating Officer
Sold at will
333
$17.58K
4.5%
21 Jun 2024
Chief Operating Officer
Sold at will
3,366
$188.80K
33.3%
5 decisions on file.